Targeted delivery and pH-responsive release of stereoisomeric anti-cancer drugs using β-cyclodextrin assemblied Fe3O4 nanoparticles

2015 ◽  
Vol 357 ◽  
pp. 2077-2086 ◽  
Author(s):  
Congli Wang ◽  
Lizhen Huang ◽  
Shengmei Song ◽  
Bassam Saif ◽  
Yehong Zhou ◽  
...  
2018 ◽  
Vol 3 (1) ◽  
pp. 150-158 ◽  
Author(s):  
Gokhan Yilmaz ◽  
Emine Guler ◽  
Caner Geyik ◽  
Bilal Demir ◽  
Melek Ozkan ◽  
...  

Over the past decade, there has been a great deal of interest in the integration of nanotechnology and carbohydrates.


RSC Advances ◽  
2015 ◽  
Vol 5 (60) ◽  
pp. 48586-48595 ◽  
Author(s):  
Ali Pourjavadi ◽  
Zahra Mazaheri Tehrani ◽  
Seyed Hassan Hosseini

In the present study, we designed a pH-responsive drug nanocarrier based on polyamidoamine-modified Fe3O4 nanoparticles coated by PEGylated starch-co-poly(acrylic acid).


2017 ◽  
Vol 13 (12) ◽  
pp. 1647-1659 ◽  
Author(s):  
Jun Cao ◽  
Haoran Zheng ◽  
Rui Hu ◽  
Jianhong Liao ◽  
Zengming Fei ◽  
...  

RSC Advances ◽  
2014 ◽  
Vol 4 (46) ◽  
pp. 24232-24239 ◽  
Author(s):  
Xubo Zhao ◽  
Peng Liu

A novel graphene oxide (GO)-based nanocarrier has been designed for the targeting and pH-responsive controlled release of anti-cancer drugs.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ran Li ◽  
Yimei Wang ◽  
Jie Du ◽  
Xiangyu Wang ◽  
Ailin Duan ◽  
...  

AbstractIn the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency.


Sign in / Sign up

Export Citation Format

Share Document